Full Length Research Paper
References
|
Al-Agamy MH, Shibl AM, Tawfik AF (2009). Prevalence and molecular characterization of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia. Annals of Saudi Medecine 29(4):253-257. |
|
|
Anna O, Soderquist B, Persson K, Molling P (2014). Characterization of CTXâ€Mâ€producing Escherichia coli by repetitive sequenceâ€based PCR and realâ€time PCRâ€based replicon typing of CTXâ€Mâ€15 plasmids 122(11):1136-1143. |
|
|
Arlet G, Philippon A (2003). The new β-lactamases at the dawn of the third millennium. French review of laboratories 352:41-55. |
|
|
Bonnet R, Sampaio JL, Chanal C, Sirot D, De Champs C, Viallard J, Labia R, Sirot J (2000). A novel class A extended-spectrum β-lactamase (BES-1) in Serratia marcescens isolated in Brazil. Antimicrobial. Agents Chemotherapy 44(11):3061-3068. |
|
|
Bradford PA (2001). Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology and detection of this important resistance threat. Clinical Microbiology Reviews 14(4):933-951. |
|
|
Brisse S, Verhoef J (2001). Phylogenetic diversity of Klebsiella pneumoniae and Klebsiella oxytoca clinical isolates revealed by randomly amplified polymorphic DNA, gyrA and parC genes sequencing and automated ribotyping. International Journal of Systematic and Evolutionary Microbiology 51(3):915-924. |
|
|
CASFM/EUCAST (2018). Antibiotic Committee of the French Microbiology Society, Recommendation 2018. View 09/09/2018 |
|
|
Cattoir V (2008). Les nouvelles β-lactamases à spectre étendu (BLSE). |
|
|
Haeggman S, Lofdahl S, Paauw A, Verhoef J, Brisse S (2004). Diversity and evolution of the class A chromosomal beta-lactamase gene in Klebsiella pneumoniae. Antimicrobial Agents Chemotherapy 48(7):2400-2408. |
|
|
Jasovsky D, Littmann J, Zorzet A, Cars O (2016). Antimicrobial resistance a threat to the world's sustainable developpement. Upsala Journal of Medical Sciences 121(3):159-164. |
|
|
Lagha N (2015). Antibiotic resistance study of extended spectrum β-lactamase-producing Enterobacteriaceae (ESBL) isolated from Laghouat Hospital: Alger. |
|
|
Liakopoulos A, Mevius D, Ceccarelli D (2016). A Review of SHVExtended-Spectrum β-Lactamases:Neglected Yet Ubiquitous. Frontiers in Microbiology 7:1374. |
|
|
Metuor-Dabiré A (2014). Molecular and kinetic characterization of broad-spectrum β-lactamase (ESBL) types of bacterial strains collected at Charles De Gaulle Paediatric Teaching Hospital (CHUP/CDG): Ouagadougou. |
|
|
Ouédraogo A (2017). Prévalence, circulation et caractérisation des bacteries multirésistantes au Burkina faso: Hal Id: tel-01476152 Spécialité/ Biologie Santé. |
|
|
Philippon A, Arlet G (2006). β-Lactamases of Gram négatif bacteria: Never-ending clockwork. Annals of Clinical Biology 64(1):37-51. |
|
|
Ribeiro Junior JC, Tamanini R, Soares BF, Marangon de Oliveira A, Silva F (2016). Efficiency of boiling and four other methods for genomic DNA extraction of deteriorating spore-forming bacteria from milk. Agricultural Sciences 37(5):3069-3078. |
|
|
Sadeeq UR, Tariq A, Ijaz A, Nazir AK, Bo H, Jian G (2018). The Growing Genetic and Functional Diversity of Extended Spectrum Beta-Lactamases. BioMed Research International 2018:9519718. |
|
|
Thomson KS, Moland ES (2000). The new β-lactamases of Gram negative bacteria at the dawn of the new millennium. Microbes Infection 2(10):1225-1235. |
|
|
Villegas MV, Kattan JN, Quinteros MG, Casellas JM (2008). Prevalence of extended-spectrum β-lactamases in South America. Clinical Microbiology and Infection 14:154 158. |
|
|
WHO (2018). High levels of antibiotic resistance found worldwide, new data shows. |
|
|
Zubair M, Malik A, Ahmad J (2015). Microbiology of Diabetic Foot Ulcer with Special Reference to ESBL Infections. American Journal of Clinical and Experimental Medicine 3(1):6-23. |
|
Copyright © 2022 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
